RVL Pharmaceuticals PLC
Biotechnology
Healthcare
RVLP
92.76 M shares
NASDAQ US
traded
17 Mar 2023
listed
yes
open
1.27
52 week high
2.91
high
1.42
52 week low
0.98
previous Close
1.33
P/E ratio
market cap
114 M
div yield
0
net incoming
-14.45 M
-19.33 %
net profit margin
-144.14 %
-0.84 %
operating incoming
-13.92 M
-15.00 %
net change in cash
32.34 M
2.00 %
cash on hand
59.75 M
117.97 %
cost of revenue
2.53 M
13.38 %
top